Literature DB >> 9787120

Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects.

X Gan1, L Zhang, T Newton, S L Chang, W Ling, V Kermani, O Berger, M C Graves, M Fiala.   

Abstract

The effects of cocaine infusion (40 mg) on interferon-gamma (IFN-gamma) and interleukin-10 (IL-10) cytokine secretion were examined in 15 cocaine-dependent subjects. Pre- and postcocaine infusion peripheral blood mononuclear cells (PBMC), stimulated with phytohemagglutinin A, were cultured for 48 h and the cytokines in the supernatant measured by enzyme-linked immunosorbent assay. Cocaine infusion, but not saline infusion, increased IFN-gamma secretion and decreased IL-10 secretion, while, in PBMC collected simultaneously from control subjects, secretion of these cytokines was unaltered. Baseline IFN-gamma levels were lower and IL-10 levels higher in addicted subjects compared to those in control subjects. White blood cell and lymphocyte number and CD4(+) and CD8(+) counts were all increased following cocaine infusion. In vitro cocaine treatment of PBMC from addicted subjects suppressed both IL-10 and IFN-gamma secretion. These data suggest that acute cocaine administration, via both central and peripheral effects, may enhance Th1-type immune responses and inhibit Th2-type responses. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9787120     DOI: 10.1006/clin.1998.4607

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  14 in total

Review 1.  Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Blaise Mathias-Costa; Vijeta Singh; Pankaj Seth; John Wang; Tsung-Ping Su
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

2.  Cocaine causes increased type I interferon secretion by both L929 cells and murine macrophages.

Authors:  K Grattendick; D B Jansen; D L Lefkowitz; S S Lefkowitz
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 3.  Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier.

Authors:  Marianne Strazza; Vanessa Pirrone; Brian Wigdahl; Michael R Nonnemacher
Journal:  Brain Res       Date:  2011-05-14       Impact factor: 3.252

Review 4.  Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems.

Authors:  Christina C Marasco; Cody R Goodwin; Danny G Winder; Nicole L Schramm-Sapyta; John A McLean; John P Wikswo
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-05

5.  Cocaine-mediated induction of platelet-derived growth factor: implication for increased vascular permeability.

Authors:  Honghong Yao; Ming Duan; Shilpa Buch
Journal:  Blood       Date:  2010-12-08       Impact factor: 22.113

6.  Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells.

Authors:  Milan Fiala; Amy J Eshleman; John Cashman; Justin Lin; Albert S Lossinsky; Vannina Suarez; Wendy Yang; Jun Zhang; Waldemar Popik; Elyse Singer; Francesco Chiappelli; Eva Carro; Martin Weinand; Marlys Witte; James Arthos
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

7.  Oral Enrichment of Streptococcus and its Role in Systemic Inflammation Related to Monocyte Activation in Humans with Cocaine Use Disorder.

Authors:  Xiaoyu Fu; Da Cheng; Zhenwu Luo; Amanda Wagner; Sylvia Fitting; Xiaomei Cong; Wanli Xu; Kendra Maas; Zhuang Wan; Jian Zhu; Zejun Zhou; William W Stoops; Aimee McRae-Clark; Wei Jiang
Journal:  J Neuroimmune Pharmacol       Date:  2021-08-26       Impact factor: 7.285

8.  Stimulant use is associated with immune activation and depleted tryptophan among HIV-positive persons on anti-retroviral therapy.

Authors:  Adam W Carrico; Mallory O Johnson; Stephen F Morin; Robert H Remien; Elise D Riley; Frederick M Hecht; Dietmar Fuchs
Journal:  Brain Behav Immun       Date:  2008-08-03       Impact factor: 7.217

Review 9.  Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.

Authors:  Jennifer M Loftis; Marilyn Huckans
Journal:  Pharmacol Ther       Date:  2013-04-28       Impact factor: 12.310

10.  A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.

Authors:  Anupa Kamat; Vikas Misra; Edana Cassol; Petronela Ancuta; Zhenyu Yan; Cheng Li; Susan Morgello; Dana Gabuzda
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.